Back to Search
JONATHAN SACKNER-BERNSTEIN, M.D.
M.D.
Internal Medicine Physician
NPI: 1760594295Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
177018-1(NY)
Cardiovascular Disease Physician
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
177018-1(NY)
Research & Publications (20)
Nesiritide for acute decompensated heart failure: does the benefit justify the risk?
PMID 17470331·Curr Cardiol Rep·2007
6-review
Practical guidelines to optimize effectiveness of beta-blockade in patients postinfarction and in those with chronic heart failure.
PMID 15144942·Am J Cardiol·2004
6-review
Neurohormonal antagonism in heart failure: what is the optimal strategy?
PMID 15029403·Mt Sinai J Med·2004
6-review
What is the role of biventricular pacing the transplant candidate?
PMID 15024294·Coron Artery Dis·2004
6-review
New evidence from the CAPRICORN Trial: the role of carvedilol in high-risk, post-myocardial infarction patients.
PMID 14564231·Rev Cardiovasc Med·2003
6-review
How should diuretic-refractory, volume-overloaded heart failure patients be managed?
PMID 14519893·J Invasive Cardiol·2003
6-review
Activation and release of degradative proteinases within the myocardium are the trigger for ventricular remodeling in chronic heart failure.
PMID 11863394·Med Hypotheses·2002
8-other
The myocardial matrix and the development and progression of ventricular remodeling.
PMID 10980881·Curr Cardiol Rep·2000
6-review
Management of diuretic-refractory, volume-overloaded patients with acutely decompensated heart failure.
PMID 15865862·Curr Cardiol Rep·2005
6-review
Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials.
PMID 15840865·JAMA·2005
1-meta
Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.
PMID 15781736·Circulation·2005
1-meta
Adherence with once daily versus twice daily carvedilol in patients with heart failure: the Compliance And Quality of Life Study Comparing Once-Daily Controlled-Release Carvedilol CR and Twice-Daily Immediate-Release Carvedilol IR in Patients with Heart Failure (CASPER) Trial.
PMID 19477398·J Card Fail·2009
4-observational
Rationale and design of CASPER: compliance and quality of life study comparing once-daily carvedilol CR and twice-daily carvedilol IR in patients with heart failure.
PMID 17023234·Am J Cardiol·2006
8-other
Risk of death associated with nesiritide in patients with acutely decompensated heart failure.
PMID 17003394·JAMA·2006
8-other
Reducing the risks of sudden death and heart failure post myocardial infarction: utility of optimized pharmacotherapy.
PMID 16450809·Clin Cardiol·2005
6-review
Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart disease.
PMID 15076165·J Hypertens·2004
7-preclinical
Role of beta-blocker therapy in the postmyocardial infarction patient with and without left ventricular dysfunction consensus guideline.
PMID 18340127·Crit Pathw Cardiol·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 423 W 55TH ST, 4TH FLOOR
NEW YORK, NY 10019 - Phone
- (212) 994-5100
Quick Facts
- NPI
- 1760594295
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile